Palliative Care Module 2

Quiz Summary

0 of 20 Questions completed

Questions:

You have already completed the quiz before. Hence you can not start it again.

Quiz is loading…

You must sign in or sign up to start the quiz.

You must first complete the following:

Results

Quiz complete. Results are being recorded.

Results

0 of 20 Questions answered correctly

Your time:

You have reached 0 of 0 point(s), (0)

Average score
Your score

Current
Review
Answered
Correct
Incorrect

Question 1 of 20

1. Question
Which of the following is the recommended starting dose of immediate release morphine for opioid naive patients?
- 5 to 10mg
- 15 to 20mg
- 10 to 15mg
- 2.5mg to 5mg
Correct

Incorrect
Question 2 of 20

2. Question
When should ‘when required’ doses of morphine be prescribed?
- For breakthrough, episodic, or incident pain
- Only for breakthrough pain
- Only for incident pain
- Only for episodic pain
Correct

Incorrect
Question 3 of 20

3. Question
How should the total 24 hour dose of immediate release morphine be calculated when converting to a long-acting preparation?
- Divide the breakthrough and regular dosing by 2
- Multiply the breakthrough and regular dosing by 2
- Add the breakthrough and regular dosing
- Subtract the breakthrough and regular dosing
Correct

Incorrect
Question 4 of 20

4. Question
What should be done if a patient can no longer swallow but still requires pain relief?
- Give the total 24 hour oral dose by continuous subcutaneous infusion
- Decrease the total 24 hour oral dose
- Increase the total 24 hour oral dose
- Stop the pain relief medication
Correct

Incorrect
Question 5 of 20

5. Question
Which of the following is the recommended starting dose for oxycodone immediate release capsules or liquid in opioid naive patients?
- 1⁄10th to 1⁄12th of the regular 24 hour dose
- 1⁄2 of the regular 24 hour dose
- 1⁄5th to 1⁄6th of the regular 24 hour dose
- The full regular 24 hour dose
Correct

Incorrect
Question 6 of 20

6. Question
How should the total daily dose of oxycodone be calculated when converting to a long-acting preparation?
- Divide the total daily dose of oxycodone required from 'breakthrough' and regular dosing by 2
- No calculation is needed
- Subtract the total daily dose of oxycodone required from 'breakthrough' and regular dosing by 2
- Multiply the total daily dose of oxycodone required from 'breakthrough' and regular dosing by 2
Correct

Incorrect
Question 7 of 20

7. Question
Which of the following is NOT a recommended management strategy for delirium?
- Routine use of anticholinergic agents
- Using psychological interventions
- Ensuring a safe and secure environment
- Treating the underlying organic causes
Correct

Incorrect
Question 8 of 20

8. Question
Which antipsychotic drug is traditionally the drug of choice for delirium?
- Haloperidol
- Olanzapine
- Quetiapine
- Risperidone
Correct

Incorrect
Question 9 of 20

9. Question
What is the maximum daily dose of haloperidol that should be used in older patients to avoid extrapyramidal side effects?
- 3mg
- 50% of daily dose
- 5-10mg
- 1-2 mg
Correct

Incorrect
Question 10 of 20

10. Question
Which drug should be used for delirium in cases of HIV, hepatic encephalopathy, or alcohol withdrawal?
- Benzodiazepines
- Haloperidol
- Risperidone
- Risperidone
- Olanzapine
Correct

Incorrect
Question 11 of 20

11. Question
Which of the following intervention is NOT an appropriate management strategy for hypersalivation?
- Using atropine eye drops in the mouth
- Using ipratropium bromide nasal spray in the mouth
- Using botulinum toxin to salivary glands
- Using pilocarpine solution
Correct

Incorrect
Question 12 of 20

12. Question
What percentage of all dementia cases is considered early-onset?
- 1%
- 70%
- 30%
- 10%
Correct

Incorrect
Question 13 of 20

13. Question
What is terminal agitation?
- A prolonged delirium
- A natural part of the dying process
- A dysregulation of the sleep-wake cycle
- A symptom of sleep phase disorder
Correct

Incorrect
Question 14 of 20

14. Question
What is terminal agitation most often mistaken for by care staff in a residential care setting?
- Behavioral and psychological symptoms of dementia
- Depression
- Anxiety
- Delirium
Correct

Incorrect
Question 15 of 20

15. Question
Which of the following is the biggest contributing factor to weakness in individuals approaching death?
- Cachexia
- Paraneoplastic syndromes
- Motor neurone disease
- Asthenia
Correct

Incorrect
Question 16 of 20

16. Question
Which of the following is NOT a potential cause of weakness in individuals approaching death?
- Age-related loss of muscle mass
- Metabolic problems
- Neuromuscular damage by tumor
- Decreased food intake
Correct

Incorrect
Question 17 of 20

17. Question
Which of the following is NOT a recommended strategy for improving nutrition in palliative care?
- Maintaining comfort and providing weight gain throughout the terminal phase
- Providing food choices that are appealing on multiple sensory levels
- Creating an environment that allows for social interaction around meal times
- Lifting dietary restrictions and discussing with the patient's family that food intake is no longer for sustaining life
Correct

Incorrect
Question 18 of 20

18. Question
What is one of the enablers for deprescribing?
- Inconvenience of medication taking
- Fear of increased adverse effects
- Patient reluctance
- Feelings of hopelessness
Correct

Incorrect
Question 19 of 20

19. Question
What is the recommended approach for deprescribing medications?
- Deprescribe one or two medications at a time
- Deprescribe all medications at once
- Deprescribe medications without considering efficacy
- Deprescribe only if the patient is not worth treating
Correct

Incorrect
Question 20 of 20

20. Question
Which medication is NOT recommended to be deprescribed in patients with heart failure?
- Beta-blockers
- Statins
- Oral hypoglycaemics (OHGs)
- Diuretics
Correct

Incorrect

Palliative Care Module 2

Quiz Summary

Information

Results

Results

Categories

1. Question

2. Question

3. Question

4. Question

5. Question

6. Question

7. Question

8. Question

9. Question

10. Question

11. Question

12. Question

13. Question

14. Question

15. Question

16. Question

17. Question

18. Question

19. Question

20. Question